Skip to main content
Contact Us
Subscribe
E-Edition
30°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Catalent Inc
(NY:
CTLT
)
39.46
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EST, Nov 28, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
39.46
Bid (Size)
30.28 (1)
Ask (Size)
44.38 (4)
Prev. Close
39.46
Today's Range
39.46 - 39.46
52wk Range
31.80 - 74.49
Shares Outstanding
170,341,553
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Intel To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Thursday
November 16, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
What 9 Analyst Ratings Have To Say About Catalent
November 16, 2023
Via
Benzinga
Performance
YTD
-13.18%
-13.18%
1 Month
-1.15%
-1.15%
3 Month
-17.46%
-17.46%
6 Month
-9.47%
-9.47%
1 Year
-15.90%
-15.90%
More News
Read More
Catalent's Q1 Performance Beat Expectations: Analyst Says Main Focus On Manufacturing Outlook For Sarepta's Gene Therapy
November 15, 2023
Via
Benzinga
Target Reports Earnings Beat, Joins AST SpaceMobile, Dada Nexus And Other Big Stocks Moving Higher On Wednesday
November 15, 2023
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Recap: Catalent Q1 Earnings
November 15, 2023
Via
Benzinga
Preview: Catalent's Earnings
November 14, 2023
Via
Benzinga
Analyst Ratings for Catalent
September 29, 2023
Via
Benzinga
US Stocks On Track To Build On Gains As Traders Await A Batch Of Data; Can Market Resist Profit Taking?
November 15, 2023
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Catalent, Inc. Reports Preliminary First Quarter Fiscal 2024 Results and Reaffirms Full-Year Fiscal 2024 Guidance
November 15, 2023
From
Catalent, Inc.
Via
Business Wire
Sotera Health Appoints Karen Flynn to Board of Directors
November 13, 2023
From
Sotera Health Services, LLC
Via
GlobeNewswire
BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion Stake
November 07, 2023
Via
Investor's Business Daily
What's Going On With Biotech Contract Service Firm Catalent Stock Today?
October 31, 2023
Via
Benzinga
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 31, 2023
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Catalent, Inc. Announces First Quarter Fiscal Year 2024 Earnings Conference Webcast
October 31, 2023
From
Catalent, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
October 31, 2023
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
October 30, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 19, 2023
Via
Benzinga
Weight-Loss Drug Boom Has Another Ripple Effect - Rapid Growth Expected In Fill-Finish Market
October 09, 2023
Via
Benzinga
CATALENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Catalent, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
September 27, 2023
From
Bragar Eagel & Squire
Via
GlobeNewswire
Flee to Healthcare Stocks if Recession Rears its Head?
September 20, 2023
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Catalent Appoints David McErlane as Biologics Segment Leader
September 18, 2023
From
Catalent, Inc.
Via
Business Wire
Catalent Receives NYSE Notice Regarding Late Form 10-K Filing
September 15, 2023
From
Catalent, Inc.
Via
Business Wire
3 Debt-Ridden S&P 500 Stocks to Sell Before It’s Too Late
September 07, 2023
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Catalent, Inc. to Present at September Investor Conferences
September 07, 2023
From
Catalent, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
September 05, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.